Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tissue Repair Ltd ( (AU:TRP) ) has issued an announcement.
Tissue Repair Ltd reported a 54.5% increase in revenue to $305,820 for the half-year ended 31 December 2025, while narrowing its loss after tax by 15.1% to $2.17 million compared with the prior corresponding period. The company did not declare any dividends, and net tangible assets per share declined from 25.77 cents to 19.57 cents, indicating ongoing investment and cash burn as it progresses its operations, with its half-year financial statements reviewed by auditors without noted disputes.
The results underscore a business that is still loss-making but showing improving revenue traction and reduced losses, which may reassure investors about operational momentum despite balance sheet dilution. The absence of dividends and the fall in net tangible assets per share highlight that shareholders remain reliant on future growth and commercialisation milestones for value, rather than near-term cash returns.
The most recent analyst rating on (AU:TRP) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on Tissue Repair Ltd stock, see the AU:TRP Stock Forecast page.
More about Tissue Repair Ltd
Tissue Repair Ltd operates in the healthcare sector, focusing on developing and commercialising wound care and tissue repair products. The company targets clinical applications where improved healing and skin regeneration therapies can address significant unmet medical needs.
Average Trading Volume: 118,325
Technical Sentiment Signal: Sell
Current Market Cap: A$9.98M
Learn more about TRP stock on TipRanks’ Stock Analysis page.